Piper Jaffray Appoints Dr. Charles Duncan to Expand Biotechnology Research Platform

  Piper Jaffray Appoints Dr. Charles Duncan to Expand Biotechnology Research

Business Wire

MINNEAPOLIS -- December 10, 2012

Piper Jaffray (NYSE: PJC) is pleased to announce the addition of Dr. Charles
Duncan as managing director and senior research analyst in its biotechnology
research platform. He will be based in the firm’s New York office, focused
specifically on small- and mid-cap emerging growth biotechnology companies.

Duncan brings more than 17 years of sell-side experience, most recently
serving as an analyst at JMP Securities since 2002, and previously at Dresdner
Kleinwort Wasserstein, Vector Healthcare Group - Prudential Securities, Tucker
Anthony Cleary Gull and Chatfield Dean & Co. Duncan has been recognized by
industry sources, including the StarMine Analyst Awards, as being among the
best analysts for his fundamental and timely analysis.

"Piper Jaffray is highly committed to further advancing its market leading
position in specialty areas of healthcare, including biotechnology. Charles
adds experience to an already well-established platform, now with a total of
four senior analysts and a significant coverage footprint across specialty
pharmaceuticals and biotechnology sectors,” commented Jeff Klinefelter, global
head of equities for Piper Jaffray. “The firm will continue to focus efforts
on providing growth companies with strategic alternatives for funding, while
offering investors opportunities to participate in early-stage growth in
exciting areas of drug discovery."

Duncan began his career as a manager of clinical development at Global Drug
Development, Inc., a pharmaceutical development consulting firm where he also
launched InfusionVision Medical, a venture-backed start-up medical device
company. He is a graduate of the University of Wisconsin and holds a doctorate
in neuropharmacology from the University of Colorado.

Piper Jaffrayhas a total of 30 senior research analysts located
inMinneapolis,New York,San Francisco andChicago. The firm provides
coverage on 565 companies globally in key sectors: business and financial
services; clean technology and renewables; consumer; healthcare; industrials;
and technology, media and telecommunications.

About Piper Jaffray
Piper Jaffray is a leading investment bank and asset management firm serving
clients in the U.S. and internationally. Proven advisory teams combine deep
industry, product and sector expertise with ready access to capital. Founded
in 1895, the firm is headquartered in Minneapolis and has offices across the
United States and in London and Zurich. www.piperjaffray.com

Since 1895. Member FINRA, NYSE and SIPC.
© 2012 Piper Jaffray & Co.


Piper Jaffray Companies
Pamela Steensland, +1 612-303-8184
Press spacebar to pause and continue. Press esc to stop.